Back
Trinity Biotech PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
1
TRIB
Trinity Biotech PLC
Last Price:
1.27
Seasonality Move:
-6%
Sell
18
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.99
Seasonality Move:
-36.59%
Sell
1
Trinity Biotech PLC (TRIB)
is a Sell
Is Trinity Biotech PLC a Buy, Sell or Hold?
- The current Trinity Biotech PLC [TRIB] share price is $1.26. The Score for TRIB is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- TRIB is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
18
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.00. The Score for ADAP is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TRIB Stock Price Chart
What is Trinity Biotech PLC's stock price today?
-
The Trinity Biotech PLC share price today is $1.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRIB is experiencing slight selling pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
TRIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 25.4 | Sell |
| Chaikin Money Flow: | -31896 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.54 - 2.22) | Sell |
| Bollinger Bands (100): | (1.65 - 2.75) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 37.11 | Sell |
| Chaikin Money Flow: | -298062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.22) | Sell |
| Bollinger Bands (100): | (0.99 - 1.23) | Sell |
TRIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.51 | Sell |
| 20-day SMA: | 1.77 | Sell |
| 50-day SMA: | 2.37 | Sell |
| 200-day SMA: | 2.22 | Sell |
| 8-day EMA: | 1.49 | Sell |
| 20-day EMA: | 1.75 | Sell |
| 50-day EMA: | 2.07 | Sell |
| 200-day EMA: | 2.43 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.06 | Sell |
| 20-day SMA: | 1.14 | Sell |
| 50-day SMA: | 1.16 | Sell |
| 200-day SMA: | 1.1 | Sell |
| 8-day EMA: | 1.05 | Sell |
| 20-day EMA: | 1.1 | Sell |
| 50-day EMA: | 1.12 | Sell |
| 200-day EMA: | 1.1 | Sell |
Trinity Biotech PLC Earnings Growth & TRIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.46 per share, an increase next quarter of $0.23 per share, a decrease this year of $1.71 per share, and an increase next year of $1.08 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.
Trinity Biotech PLC Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||